In eight of these, we examined 12 surface markers commonly used in myeloma research, while in four cases we studied only a subset of them (CD38, CD44, CD45, CD49d, CD69, CD86, CD138, and CD184). This evidence concerns the gene ITGA4 and plasma cell myeloma.